Table 2.
N (%) with RA/ReA-associated medical encounters |
Median (IQR) Visits Per Subject |
|||
---|---|---|---|---|
RA | ReA | RA | ReA | |
Arthrocentesis | 153 (30.6) | 174 (34.8) | 1.0 (1.0, 3.0) | 1.0 (1.0, 3.0) |
Magnetic Resonance Imaging (MRI) | 187 (37.4) | 112 (22.4) | 2.0 (1.0, 3.0) | 1.0 (1.0, 2.0) |
Mitochondrial Antibody | 10 (2.0) | 4 (0.8) | 1.0 (1.0, 1.0) | 1.0 (1.0, 1.0) |
Actin Smooth Muscle Antibody | 14 (2.8) | 1 (0.2) | 1.0 (1.0, 1.0) | 1.0 (1.0, 1.0) |
Anti-nuclear Antibody | 24 (4.8) | 6 (1.2) | 1.0 (1.0, 1.0) | 1.0 (1.0, 1.0) |
Extractable Nuclear Antigen Antibody | 23 (4.6) | 5 (1.0) | 1.0 (1.0, 1.0) | 1.0 (1.0, 1.0) |
Rheumatoid Factor | 33 (6.6) | 4 (0.8) | 1.0 (1.0, 1.0) | 1.0 (1.0, 1.0) |
Rheumatology Clinic | 179 (35.8) | 255 (51.0) | 6.0 (2.0, 12.0) | 3.0 (2.0, 5.0) |